On March 20, 2025, Dr. Peter Salzmann announced he will not seek re-election to the Board of Corbus Pharmaceuticals, leading to a reduction in Board size from eight to seven members effective at the 2025 Annual Meeting; his decision was not due to any disagreements with the Company.